Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 6,244,800 | 4,307,100 | 2,855,400 | 1,902,900 | 5,581,700 |
| Depreciation Amortization | 1,522,500 | 1,147,500 | 784,600 | 435,700 | 1,547,600 |
| Income taxes - deferred | -2,185,200 | -2,195,600 | -1,125,000 | -506,600 | -802,300 |
| Accounts receivable | -299,600 | N/A | N/A | N/A | -1,278,300 |
| Accounts payable and accrued liabilities | 1,692,000 | N/A | N/A | N/A | -1,013,800 |
| Other Working Capital | -800 | 312,100 | -104,200 | -34,300 | -1,012,600 |
| Other Operating Activity | 612,000 | 2,351,900 | 1,295,500 | 725,300 | 4,343,600 |
| Operating Cash Flow | $7,585,700 | $5,923,000 | $3,706,300 | $2,523,000 | $7,365,900 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 14,000 | 18,100 | 24,700 | 12,100 | -36,100 |
| PPE Investments | -1,854,300 | -1,353,600 | -736,400 | -365,400 | -1,309,800 |
| Net Acquisitions | -327,200 | N/A | N/A | N/A | -747,400 |
| Purchase Of Investment | -600,200 | -474,100 | -251,400 | -116,700 | -929,900 |
| Sale Of Investment | 342,200 | 251,600 | 168,500 | 81,400 | 800,000 |
| Purchase Sale Intangibles | N/A | 65,800 | N/A | N/A | N/A |
| Other Investing Activity | -1,337,400 | -1,261,400 | -1,069,500 | -649,000 | -644,300 |
| Investing Cash Flow | $-3,762,900 | $-2,819,400 | $-1,864,100 | $-1,037,600 | $-2,867,500 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 1,741,300 | 2,117,200 | 499,700 | N/A |
| Debt Issued | 1,498,000 | N/A | -1,560,000 | N/A | 2,406,800 |
| Debt Repayment | -1,560,000 | -1,560,000 | N/A | -710,100 | -1,905,400 |
| Common Stock Repurchased | -1,500,000 | -1,500,000 | -1,500,000 | -1,500,000 | -1,250,000 |
| Dividend Paid | -3,535,800 | -2,651,400 | -1,769,200 | -885,500 | -3,086,800 |
| Other Financing Activity | -308,900 | -295,200 | -290,000 | -282,400 | -295,900 |
| Financing Cash Flow | $-5,406,700 | $-4,265,300 | $-3,002,000 | $-2,878,300 | $-4,131,300 |
| Exchange Rate Effect | -167,600 | -39,400 | -35,800 | 33,600 | -205,700 |
| Beginning Cash Position | 3,818,500 | 3,818,500 | 3,818,500 | 3,818,500 | 3,657,100 |
| End Cash Position | 2,067,000 | 2,617,400 | 2,622,900 | 2,459,200 | 3,818,500 |
| Net Cash Flow | $-1,751,500 | $-1,201,100 | $-1,195,600 | $-1,359,300 | $161,400 |
| Free Cash Flow | |||||
| Operating Cash Flow | 7,585,700 | 5,923,000 | 3,706,300 | 2,523,000 | 7,365,900 |
| Capital Expenditure | -1,854,300 | -1,353,600 | -736,400 | -365,400 | -1,309,800 |
| Free Cash Flow | 5,731,400 | 4,569,400 | 2,969,900 | 2,157,600 | 6,056,100 |